General contact

Head Office
Novartis International AG
CH-4002 Basel
Switzerland

+41 61 324 11 11
+41 61 324 80 01
Monday - Friday,
8:30 - 17:00, GMT+1
(Central European Time)

Investors

Novartis International AG
Investor Relations
P.O. Box
CH-4002 Basel
Switzerland

+41 61 324 79 44

Media

Global Media Relations
Eric Althoff
Basel, Switzerland

+41 61 324 7999

Reporting side effects

Report a suspected side effect (also known as an adverse event) related to a Novartis Pharmaceutical drug or a Novartis Vaccine.

Reporting side effects

pane 4 content

R&D

Novartis Institutes for BioMedical Research (NIBR) is the global pharmaceutical research organization for Novartis, committed to discovering innovative medicines that treat disease and improve human health. Headquartered in the United States in Cambridge, Massachusetts, the NIBR research network includes a major research center in Basel, Switzerland, and additional centers in Shanghai, China and elsewhere.

Novartis Institutes for BioMedical Research (NIBR) in Basel, Switzerland

NIBR research, Basel
NIBR research, Basel
Farbikstrasse 16 Lab
Fabrikstrasse 16 Lab
Laboratory Fabrikstrasse 14
Laboratory Fabrikstrasse 14
NIBR compound archive, Basel
NIBR compound archive, Basel
NIBR Fabrikstrasse 10
NIBR Fabrikstrasse 10
NIBR Fabrikstrasse 22
NIBR Fabrikstrasse 22
NIBR Fabrikstrasse 22
NIBR Fabrikstrasse 22
NIBR Fabrikstrasse 22
NIBR Fabrikstrasse 22
NIBR Fabrikstrasse 22
NIBR Fabrikstrasse 22
NIBR Fabrikstrasse 22
NIBR Fabrikstrasse 22
NIBR Fabrikstrasse 22
NIBR Fabrikstrasse 22
NIBR Fabrikstrasse 22
NIBR Fabrikstrasse 22

Novartis Institutes for BioMedical Research (NIBR) in Shanghai, China

Chemistry laboratory at NIBR Shanghai
Chemistry laboratory at NIBR Shanghai
Chemistry laboratory at NIBR in Shanghai, China
Chemistry laboratory at NIBR in Shanghai, China

You may use the multimedia material provided in this section for commercial purposes only in relation to Novartis. These images must not be modified in any way and each item must have the copyright acknowledgement of Novartis AG (© Novartis AG).